Home Cart 0 Sign in  

[ CAS No. 1232410-49-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1232410-49-9
Chemical Structure| 1232410-49-9
Structure of 1232410-49-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1232410-49-9 ]

Related Doc. of [ 1232410-49-9 ]

Alternatived Products of [ 1232410-49-9 ]

Product Details of [ 1232410-49-9 ]

CAS No. :1232410-49-9 MDL No. :MFCD19443686
Formula : C18H16N4O3S Boiling Point : -
Linear Structure Formula :- InChI Key :DUIHHZKTCSNTGM-UHFFFAOYSA-N
M.W : 368.41 Pubchem ID :51000408
Synonyms :
ATR Inhibitor IV

Calculated chemistry of [ 1232410-49-9 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.06
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 99.18
TPSA : 123.42 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 2.05
Log Po/w (WLOGP) : 3.28
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 1.68
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.6
Solubility : 0.093 mg/ml ; 0.000252 mol/l
Class : Soluble
Log S (Ali) : -4.27
Solubility : 0.0198 mg/ml ; 0.0000537 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.59
Solubility : 0.0000951 mg/ml ; 0.000000258 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.89

Safety of [ 1232410-49-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1232410-49-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1232410-49-9 ]
  • Downstream synthetic route of [ 1232410-49-9 ]

[ 1232410-49-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1232423-29-8 ]
  • [ 62-53-3 ]
  • [ 1232410-49-9 ]
YieldReaction ConditionsOperation in experiment
71% With diethyl cyanophosphonate; triethylamine In 1,2-dimethoxyethane at 120℃; for 18 h; A mixture of 3-amino-6-(4-methylsulfonylphenyl)pyrazine-2-carboxylic acid (1.5 g, 5.1 14 mmol), diethoxyphosphorylformonitrile (926.8 mg, 849.5 μL, 5.1 14 mmol), aniline (476.2 mg, 465.9 μL, 5.1 14 mmol) and triethylamine (1.035 g, 1.426 mL, 10.23 mmol) were stirred in DME (18.75 mL) at 120 °C for 18 hours. After this time water was added and the resultant solid collected by filtration. The solid was triturated with acetone and dried to give the desired product (1.335g, 71percent Yield). 1H NMR (400.0 MHz, DMSO) d 3.28 (s, 3H), 7.18 (t, J = 7.3 Hz, I H), 7.41 (t, J = 7.8 Hz, 2H), 7.82 (d, J = 7.9 Hz, 2H), 7.89 (s, 2H), 8.01 (d, J = 8.4 Hz, 2H), 8.51 (d, J = 8.4 Hz, 2H), 9.04 (s, 1H) andlψ.47 (s, I H) ppm; MS (ES+) 369
71% With diethyl cyanophosphonate; triethylamine In 1,2-dimethoxyethane at 120℃; for 18 h; Step 4: 3-Amino-6-(4-(methylsulfonyl)phenyl)-iV-phenylpyrazine-2-carboxamide[00144] A mixture of 3-amino-6-(4-methylsulfonylphenyl)pyrazine-2-carboxylic acid (1.5 g, 5.114 mmol), diethoxyphosphorylformonitrile (926.8 mg, 849.5 μ, 5.114 mmol), aniline (476.2 mg, 465.9 μ, 5.114 mmol) and triethylamine (1.035 g, 1.426 mL, 10.23 mmol) was stirred in DME (18.75 mL) at 120 °C for 18 hours. After this time water was added and the resultant solid collected by filtration and triturated with acetone to give the desired product (1.88g, 71percent Yield). 3/4 NMR (400.0 MHz, DMSO) δ 10.47 (s, 1H), 9.04 (s, 1H), 8.51 (d, J = 8.4 Hz, 2H), 8.01 (d, J = 8.4 Hz, 2H), 7.89 (s, 2H), 7.82 (d, J = 7.9 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 7.18 (t, J = 7.3 Hz, 1H) and 3.28 (s, 3H) ppm; MS (ES+) 369.0.
Reference: [1] Patent: WO2010/71837, 2010, A1, . Location in patent: Page/Page column 176
[2] Patent: WO2011/143425, 2011, A2, . Location in patent: Page/Page column 37; 39
  • 2
  • [ 16298-03-6 ]
  • [ 1232410-49-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 7, p. 2320 - 2330
  • 3
  • [ 6966-01-4 ]
  • [ 1232410-49-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 7, p. 2320 - 2330
  • 4
  • [ 486424-37-7 ]
  • [ 1232410-49-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 7, p. 2320 - 2330
  • 5
  • [ 1232423-27-6 ]
  • [ 1232410-49-9 ]
Reference: [1] Patent: WO2011/143425, 2011, A2,
Same Skeleton Products
Historical Records